Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
0
Authors
Wolfgang Hueber
Wolfgang Hueber•Dhavalkumar Patel•Franco Padova
Published
October 6, 2010
Abstract
A human antibody to interleukin-17A is well tolerated and may be effective in the treatment of psoriasis, rheumatoid arthritis, and noninfectious uveitis.